Close

content

WuXi AppTec breaks ground on new R&D and manufacturing site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science...

AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs...

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved...

Germany’s Merck KGaA acquires Mirus Bio for $600 M

Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, announced that it has entered into an agreement...

Pharma Chemicals Market To Grow At A CAGR of 5% Till 2029

It is worth noting that the pharmaceutical chemicals market happens to be segmented by Type which includes Reagents, Catalysts, Solvents, KSMs and intermediates, Building...

Europe API Market To Grow At A CAGR of Over 5.5% Till 2033

As per one of the recently held studies in 2024, the Europe Active Pharmaceutical Ingredients- API market size happened to be anticipated at $45.43...

Top Trends – Europe Active Pharmaceutical Ingredients Market

The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read